Lacharon, Ethal Ralf .
HRN: 21-45-76 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2022
CEFTRIAXONE 1G (VIAL)
06/15/2022
06/21/2022
IV
800mg
Q24
PCAP C
Waiting Final Action
Indication: EmpiricEmpirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes